Published by
@ShahidNShah
@ShahidNShah
April 21 to April 22, 2021
It is an online event.
Prioritize Anti-Infective Drug Development Pipelines that Focus on High-Value Clinical Candidates, Novel Modalities & Effective Strategies that Address Market Sustainability & Aim for Superiority. Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.
Read on anti-infectives-drug-development.com
Continue reading at anti-infectives-drug-development.com
April 22, 2021
It is an online event.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Oct 22, 2024 at 4:06am